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ABSTRACT 
Retrospective and prospective studies looking at the role of cerebrospinal fluid pressure (CSFP)/intracranial pressure 
(ICP) have stimulated new theories and hypotheses regarding the underlying causal events for glaucoma. Most recently, 
studies supporting a low CSFP/ICP as a risk factor for glaucoma have been published. This review summarizes the current 
understanding of CSFP/ICP and its potential role in the pathogenicity of the disease. 
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INTRODUCTION 
Glaucoma is defined as a collection of diseases that 
causes progressive degeneration of optic neurons.  
Characteristic damage to axonal components of the optic 
nerve head and the surrounding neuroretinal rim, also 
takes place (1, 2). Despite advances in clinical 
management strategies, glaucoma continues to be the 
leading cause of irreversible blindness worldwide (3). The 
most common form of the disease is primary open-angle 
glaucoma (POAG), and it usually manifests with an 
elevated intraocular pressure (IOP). Elevated IOP is a 
well-recognized risk factor for glaucoma (4) and is also a 
causal factor for optic neuronal damage. As a result, all 
current treatment modalities for glaucoma are geared 
toward the reduction of IOP (5). The exact sequence of 
events that cause glaucomatous optic nerve damage 
after an elevated IOP remains unclear (6, 7). In addition 
to this, a large number of patients who suffer from 
normal tension glaucoma (NTG) develop glaucomatous 
optic nerve damage despite having an IOP below 22 
mmHg (6). In fact, depending on race and ethnicity, NTG 
may be the most predominant form of glaucoma. This is 
particularly true in Asian populations where the majority 
of POAG belong to the NTG subtype (52-92%) (8). NTG 
proportions are comparatively lower in Caucasian (30-
38.9%) and African populations (57.1%) (8). Furthermore, 
there is a distinct group of patients with high IOP (ocular 
hypertension), who never develop glaucoma (7, 9). Many 
glaucoma patients whose IOP is maintained at a safe 
target level, continue to lose optic neurons with time, 
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therefore requiring a continuous reassessment of their 
target IOP (4, 10, 11). In light of these evidences, there 
clearly appears to be risk factors other than IOP that are 
involved in the progression of the glaucoma pathology. 
Probability of developing glaucoma is directly linked to 
the number and strength of risk factors (7). Other than 
elevated IOP, important risk factors include race, 
ethnicity and age. Likelihood of glaucoma was found to 
be high when there was a familial predisposition to the 
disease. Clinically, an increased or asymmetric cup to disk 
ratio and findings of disk hemorrhage were found to 
correlate strongly with subsequent development of 
glaucoma (4, 7, 12) as did a long-term treatment with 
topical corticosteroids (13). Recently a number of studies 
have shown that cerebrospinal fluid pressure (CSFP) or 
intracranial pressure (ICP) is a significant risk factor for 
glaucoma. Retrospective and prospective studies looking 
at the role of CSFP/ICP have stimulated new theories and 
hypotheses regarding the underlying causal events for 
glaucoma. In this review, we examine the current 
literature and studies regarding CSFP/ICP with reference 
to glaucoma and evaluate how findings from these 
reports can help further our knowledge in understanding 
the pathogenicity of the disease. 
 
CEREBROSPINAL FLUID PRESSURE/INTRACRANIAL 
PRESSURE 
Cerebrospinal fluid (CSF) is a continually generated 
specialized liquid secreted mostly (70-80%) by the 
choroid plexus in the lateral, third and fourth ventricles 
(14). The cerebral capillary wall also secretes a CSF like 
fluid (15), but it is not as efficient as the choroid plexus. 
Nascent CSF is much enriched by active secretion of the 
choroidal epithelium (16). The rate of CSF secretion is 
tightly regulated by multiple choroidal and extra 
choroidal mechanisms to maintain a stable CSFP/ICP (14). 
When measured by lumbar puncture, CSFP directly 
correlates with ICP and the retrolaminar pressure 
measured in the lateral decubitus position. As a result, 
ICP and CSFP have been used interchangeably in the 
medical literature and clinical practice (17-20). It should 
be remembered that while ICP indicates the pressure 
inside the cranium, CSFP is the more general term 
referring to the pressure throughout the neuroaxial 
system (18). In connection to glaucoma, ICP or the CSFP 
of the cranium is more relevant and henceforth for the 
purpose of this review, the pressure created by CSF will 
be referred to as ICP. 
 
PRESSURE COMPONENTS AFFECTING THE OPTIC NERVE: 
AN ANATOMICAL PERSPECTIVE 
The optic nerve is a myelinated tract of approximately 
1.2 million axons that start from the retinal ganglion cells 
and end after traveling approximately 50 mm to the optic 
chiasm. The optic tract is the posterior projection of the 
optic nerve beyond the optic chiasma until its 
termination (21). Of the various portions of the optic 
nerve, the intraocular part or the optic disc is clinically 
most relevant to the pathophysiology of glaucoma. This 
is the area where the characteristic optic nerve cupping 
is observed. The intraocular portion of the optic nerve 
has three distinct anatomical zones: a) the retinal or 
prelaminar zone; b) the choroidal or laminar zone; and c) 
the scleral or retrolaminar/retrobulbar zone. As the 
retinal ganglion axons make an orthogonal turn from the 
nerve fiber layer and pass through the lamina cribrosa, 
there is a sudden change in the surrounding pressure. 
The axons move from a higher IOP to a comparatively 
lower retrobulbar pressure. After emerging out of the 
lamina cribrosa and throughout its whole course, the 
optic nerve is surrounded and bathed by CSF, running 
through the sub arachnoid space and generating the so-
called retrobulbar pressure which in essence is the same 
as ICP (20). Therefore, over the span of a few millimeters, 
the optic nerve experiences two different pressure 
components - the higher IOP and the lower ICP. These 
two pressure components are separated by the lamina 
cribrosa which is a thin collagenous support of the optic 
nerve and is basically a perforated region of the posterior 
sclera that allows the retinal axons to pass into the optic 
nerve (20, 22, 23). 
 
THE LAMINA CRIBROSA AND THE TRANSLAMINAR 
PRESSURE GRADIENT 
Due to changes in pressure, the lamina cribrosa deforms 
posteriorly during glaucoma and anteriorly during 
papilledema, pseudotumor cerebri, and ocular hypotony; 
all diseases associated with loss of axons and retinal 
neurons (20, 24). Because of this, the lamina cribrosa is 
considered the anatomic landmark of interest in 
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glaucoma and other diseases where IOP and ICP are 
important contributory factors (25). As mentioned 
before, at any given time the lamina cribrosa is under the 
influence of two separate but possibly interdependent 
pressures – the posteriorly acting IOP and the anteriorly 
acting ICP. The difference in these two pressures creates 
the translaminar pressure gradient (TLPG). In addition to 
IOP and ICP, the thickness of the lamina cribrosa also 
plays a significant role in determining this pressure 
gradient (17, 26, 27). Therefore, the TLPG may be 
defined as the difference between IOP and ICP per unit 
thickness of the lamina cribrosa [(IOP-ICP)/thickness of 
the lamina cribrosa] (17). The ability of the lamina 
cribrosa to withstand this pressure gradient also depends 
on the surrounding extracellular matrix and the 
peripheral scleral tension (28). It should be noted that 
the distribution of the pressure gradient might not be 
uniform even in the presence of a constant IOP. 
According to the Law of LaPlace, the tension on the walls 
of the structure is dependent on the IOP and radius of 
curvature divided by 2 times the thickness of the wall. 
Therefore, the inherent heterogeneity of the lamina 
cribrosa also plays a significant role in determining the 
distribution of the pressure gradient (25). Another factor 
affecting the TLPG is the pulsatile movements of the 
lamina cribrosa in a coronary-sagittal plane (29). 
Although the physiologic significance of these changes is 
unclear, they may have a role in facilitating orthograde 
and retrograde axoplasmic flow (29, 30). Nevertheless, 
the integrity and resilience of the lamina cribrosa in 
maintaining its shape is extremely important for 
protecting the health of the structures that pass through 
it – mainly the axonal components of the retinal ganglion 
cells as well as the arterial and venous vessels (28, 31). In 
fact, posterior cupping of the lamina cribrosa is one of 
the hallmark pathologic manifestations of glaucoma and 
occurs quite early in the disease (32). 
The thickness of a normal lamina cribrosa is around 450 
µm with a calculated pressure gradient of about 1 mmHg 
per 100 µm (17, 33). This is one of the steepest pressure 
gradients to which a nerve is exposed in the human body 
(17). It is widely accepted that pressure gradients across 
nervous tissues can alter axonal transport (23). In 
peripheral nerve compression studies, it has been shown 
that the pressure gradient and not the absolute pressure 
increase (as high as 5 atmospheres) were responsible for 
blocking orthograde axonal transport (34-36). Given the 
fact that lamina cribrosa is under the continuous 
influence of two separate pressure components, it is 
reasonable to believe that significant pathological 
deformities of the lamina cribrosa can originate from 
changes in either pressure components. Indeed, recent 
studies clearly show that ICP is as responsible for causing 
neuronal damage at the optic nerve head as elevated IOP 
(18, 20, 27, 37-39). To acknowledge the contribution of 
ICP in glaucomatous optic nerve damage, Fleishman and 
Berdahl have postulated the CSF theory of glaucoma 
(25). According to this theory, a net balancing force 
arising out of the difference between IOP and ICP 
determines the TLPG. The TLPG is affected by changes in 
either IOP and/or ICP. For example, a reduction in ICP will 
have the same effect as an increase in IOP (Fig. 1). This 
gradient is involved in all kinds of laminar movement and 
consequently all pathologic cupping (as seen in 
glaucoma) or swelling (as seen in papilledema). A large 
body of evidence now exists to show that ICP is indeed a 
formidable risk factor for the development of glaucoma. 
 
 
Figure 1. Schematic representation of the CSF theory. 
The homeostatic translaminar pressure difference is maintained by 
the interaction of two pressure components – the higher IOP and the 
lower ICP. Changes in either parameter can cause disruption of the 
pressure gradient and lead to optic neuronal damage. Reprinted from 
Fleishman et al. (8) 
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EVIDENCE IN FAVOR OF ICP AS A RISK FACTOR FOR 
GLAUCOMA 
More than 90 years ago, Szymanski and Wladyczko 
proposed that low ICP may be a factor in the 
development of glaucoma (40). Since then, this concept 
has fallen in and out of favor over the following years. In 
1976, Volkov postulated that the retrolaminar tissue 
pressure is affected by ICP particularly because the optic 
nerve immediately beyond the lamina cribrosa is 
surrounded by CSF (41). Within a few years of this report 
Yablonski et al. published two abstracts that suggested 
glaucoma like changes in cat eyes when intracranial 
pressure was lowered below atmospheric pressure. 
These changes included axonal swelling, increased cup to 
disk ratio and cupping of the lamina cribrosa. They also 
were able to counteract this effect of low ICP by lowering 
the IOP at the same time. (Yablonski ME, et al. IOVS 
1978;17: ARVO Abstract 6; Yablonski ME, et al. IOVS 
1979;18: ARVO Abstract 8) Although these data were the 
first experimental proof of the involvement of ICP in 
glaucomatous pathology, the authors never published 
their results formally, and it is hard to comment on the 
merits of the studies. A few years later, glaucoma like 
cupping in several patients with normal IOP but suffering 
from compression of the intracranial optic nerve owing 
to tumor or other lesions were reported (42, 43). In their 
case report, Kalenak et al. mentioned a highly unusual 
unilateral NTG due to tumorigenic blockage of the optic 
nerve in one eye (42). It should be mentioned here that 
glaucoma owing to nerve compression by a pituitary 
tumor (Rathke’s cleft cyst) has also been reported in later 
years and intracranial compressive lesions are often 
taken into account during diagnosis of normal tension 
glaucoma (NTG) (44-46). Although the authors did not 
report the ICP of these patients, it is possible that due to 
compression caused by the tumor, pressure in the optic 
nerve subarachnoid space fell below the ICP and induced 
glaucoma like pathologies. Therefore, though 
unrecognized, these may be the first clinical studies 
showing the involvement of ICP in causing glaucoma like 
changes in the eye. Shortly thereafter, in a series of 
elegant studies, Morgan et al. provided solid 
experimental evidence of the importance of ICP in 
maintaining the translaminar pressure gradient and 
subsequently the health of the surrounding optic 
neuronal tissues (20). They were able to calculate the 
TLPG in a dog model and determined that both ICP and 
IOP are responsible for creating a homeostatic TLPG. The 
authors further proved that ICP in the brain is the same 
as the retrobulbar pressure owing to an anatomic and 
hydrostatic continuity of the fluid-filled tracts (20). At the 
same time, Shin et al. independently commented on the 
importance of the “retrolaminar intraoptic nerve 
pressure” on displacement of the lamina cribrosa, from 
their observations of adult glaucoma patients (47-50). 
Intracranial pressure with reference to glaucoma 
received much attention during the late 2000s, owing to 
some well-designed retrospective studies by Drs. 
Fautsch, Johnson, Allingham, Berdahl and Fleischman. To 
look for possible associations between ICP and glaucoma 
the authors used an integrated and comprehensive 
multispecialty database of the Mayo Clinic. They 
analyzed the medical history of thousands of patients 
who underwent lumbar puncture for measurement of 
ICP. Their results showed that ICP was significantly lower 
in patients with POAG compared to non-glaucomatous 
controls. Reduced ICP was also found in NTG patients 
with a statistically calculated ICP that was lower than 
that found in POAG. In contrast, ICP was elevated in 
patients with ocular hypertension in comparison to no 
disease controls (Fig. 2) (18, 37). Subsequently, the TLPG 
was found to be higher in patients with glaucoma (18). 
Correlation between ICP and other established risk 
factors for glaucoma was also investigated. In separate 
publications they reported that starting in the sixth 
decade of life, there is a “sustained and significant 
reduction” of ICP with age. The age at which ICP began to 
decrease also coincided with the age when prevalence of 
glaucoma increases (51). Additionally, body mass index 
(BMI), which has been reported to be a risk factor for 
POAG (52), was found to have a positive linear 
correlation with ICP (53). This implied that patients with 
higher BMI may be at a lower risk of developing 
glaucoma owing to a higher ICP. This concept was 
supported by a different study showing that females with 
a higher BMI had a lower risk of developing POAG (54). 
Although the authors suspected the endocrine role of 
adipose tissues behind this effect, Fleishman et al. 
believed that this was due to a concomitant increase in 
ICP in patients with higher BMI. Arguably, the elevated 
ICP in these patients can provide a compensating counter 
pressure on the lamina cribrosa and lower the propensity 
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of the optic disc to bow posteriorly in response to a 
higher IOP (55). 
 
 
Figure 2. Statistically corrected intracranial pressure across various 
groups of glaucoma and ocular hypertension (OHT), in comparison to 
respective controls.ICP was significantly lower in POAG and NTG 
groups and higher in OHT patients. Reprinted from Berdahl et al. (18).  
 
Shortly after the publication of the retrospective studies, 
several prospective studies showed that in NTG patients, 
ICP was abnormally low, causing a higher than normal 
TLPG. This pressure was even lower than that of patients 
with high-pressure glaucoma while the latter was 
significantly lower compared to normal control (56). 
These results were corroborated by animal studies 
performed on non-human primates. By lowering the ICP 
with the help of a shunt, glaucoma like pathology was 
observed in 50% of the experimental animals. These 
changes included reduced thickness of the retinal nerve 
fiber layer, reduction in area and volume of the 
neuroretinal rim, and a significant increase in cup-disk 
ratios (57). When ICP was measured non-invasively using 
a specialized transcranial Doppler, it was found that ICP 
was 2-3 mmHg lower in patients with NTG and open 
angle glaucoma when compared to healthy controls (58). 
ICP-IOP-TLPG AND THE CSF THEORY – WHAT DO THE 
DATA SIGNIFY? 
Based on convincing experimental and clinical reports, it 
is evident that ICP is a significant risk factor for glaucoma. 
Low intracranial pressure may be considered as the 
“tipping point” in scientific knowledge regarding 
glaucomatous pathology (59). Health of the optic nerve 
head along with surrounding neuronal tissue is 
maintained by a homeostatic pressure difference 
between a posteriorly directed IOP and an anteriorly 
directed ICP. These two pressure components are 
separated by the thin lamina cribrosa and give rise to the 
TLPG. Owing to the biomechanical nature of the optic 
nerve head, TLPG may be the single most important 
pressure related parameter for the development and 
progression of glaucoma (33, 60). This was also shown in 
a study where a reversal of the TLPG following Valsalva 
maneuver was found to affect the three-dimensional 
optic nerve head morphology and other parameters 
associated with glaucoma like pathologies (61). 
Therefore, as the retrospective and prospective studies 
show, an increase in IOP (as found in many glaucoma 
patients) will have the same effect on TLPG as a lowered 
ICP. In a recent case report, Chen et al. described how 
NTG of a patient worsened after ICP reduction following 
surgical implantation of a ventriculoperitoneal shunt 
(62). 
Based on the CSF theory of glaucoma, researchers have 
now found evidence linking glaucoma and Alzheimer’s 
disease (AD). Studies show that depending on race and 
ethnicity, there could be as high as a 5-fold increase in 
the prevalence of glaucoma in AD patients when 
compared to the average population (63, 64). Although 
in a small subset of patients with early AD, ICP was found 
to be elevated; the same study reported a substantially 
larger population with more advanced AD to have a 
significantly lower ICP, which subsequently gave rise to 
an abnormally high TLPG (65-67). In a recent 
retrospective study, Fleishman et al. have also reported a 
similar significantly lowered ICP in AD patients in the age 
group of 40-69 years (68). These data support the 
hypothesis that low ICP and a high TLPG found in AD 
patients could be the reason behind comorbidity of 
glaucoma and AD (69).  
Mounting evidence suggests that there may be a cross-
talk between IOP and ICP, with changes in one 
compensated by the other at least within a biological 
range. In monkeys, experimentally increased ICP was 
found to elevate IOP within a few minutes of induction. 
This phenomenon continued as long as the pressure in 
the brain was below blood pressure. ICP increases 
beyond blood pressure did not elicit any changes in the 
IOP (70). In a separate study on a population of 50 
patients, Sajjadi et al. found a high correlation between 
IOP and ICP (r=0.995) (71). Similarly, Lashutka et al. have 
shown that high IOP measured with a handheld 
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tonometer is a useful indicator of elevated ICP especially 
in patients with intracranial lesions and without 
glaucoma (72). Indeed, ICP is an important consideration 
in the diagnosis of various eye diseases (73). The 
relationship between ICP and IOP may be explained by a 
recent report by Samuels et al. where the authors have 
shown that both ICP and IOP are physiologically 
regulated by the same group of neurons in the 
dorsomedial and perifornical hypothalamus (74). 
Nevertheless, the relationship between ICP and IOP is 
not well understood, and some studies have also shown 
a lack of correlation between ICP and IOP (75, 76). 
Although changes in IOP might still be useful in providing 
some evidence to changes in ICP, the inherent variability 
of the correlation between these two parameters 
reduces its clinical significance (77). It is also possible that 
the relationship between IOP and ICP breaks down under 
pathological conditions, when one of the two changes 
outside the normal range (29).  
The reverse effect of the CSF theory can be seen in 
clinical conditions like idiopathic intracranial 
hypertension (IIH), pseudotumor cerebri and ocular 
hypotony. All of these conditions cause an unbalanced 
anteriorly directed force either due to an elevated ICP 
and normal IOP (IIH, pseudotumor cerebri) or a normal 
ICP and low IOP (ocular hypotony). The net result is a 
negative cupping effect or swelling of the optic disk – a 
condition called papilledema, with glaucoma like loss of 
retinal neurons (17, 26, 33, 78). Several case reports have 
shown development of papilledema in patients with both 
IIH and ocular hypertension, who were treated with IOP-
lowering surgery (79-81). This indicates that patients 
with IIH may tend to have ocular hypertension to 
counterbalance the increased ICP, thereby maintaining a 
homeostatic TLPG (78). Based on this, it has been 
proposed that a clinically increased IOP may be a 
treatment option for patients with papilledema (78, 82, 
3). 
The mechanical effect of the ICP component on the 
lamina cribrosa is further underscored by reports of 
“reversal of cupping” in patients whose IOP has been 
lowered below normal levels for 5 years (84, 85). 
Obviously, this reversal does not improve the visual field 
since retinal neurons once lost cannot regenerate, but it 
does indicate the importance of ICP on maintenance of 
optic nerve health. 
 
ANIMAL MODELS TO STUDY THE ROLE OF ICP IN 
GLAUCOMA 
Despite a large body of evidence in favor of the CSF 
theory, there still exist doubts as to the contribution of 
ICP in the pathogenesis of glaucoma (86). This is mainly 
due to the absence of a viable animal model where the 
relationship between ICP, IOP and relevant optic 
neuronal tissues can be studied in a controlled 
environment (59). The dog model of Morgan et al. was 
key to our understanding of the anatomic and 
physiologic significance of ICP and IOP. This model, 
through experimental alteration of ICP and IOP, also 
elaborated the mechanical role of TLPG in causing optic 
disk movements (20, 23, 87). These data highlight the 
susceptibility of optic neuronal components under 
altered IOP and/or ICP (7). However, evaluating 
glaucoma like neuronal pathologies in the eye following 
chronic changes in ICP/TLPG was beyond the scope of 
this model. To overcome this, our laboratory has recently 
designed a novel rat intraventricular cannula (IVC) 
model, which allows investigators to manually increase 
or decrease the ICP over sustained periods of time (Fig. 
3) (88). 
 
Figure 3. Schematic representation of the rat IVC model. 
ICP was monitored by connecting a pressure transducer to a surgically 
implanted cannula in the left lateral ventricle. ICP can be manually 
raised or lowered in a controlled fashion via elevation or declination 
of an artificial CSF containing reservoir connected in parallel to the 
primary setup. Reprinted from Roy Chowdhury et al. (88). 
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Using the rat IVC model, long-term lowering of ICP 
resulted in a significant reduction of retinal ganglion cell 
and optic nerve axon density (Roy Chowdhury U et al, 
IOVS 2016;56:ARVO-E abstract 4131). This model may be 
instrumental in bridging the current knowledge gap 
regarding ICP and glaucoma. Recently, Yang et al. have 
described a monkey model where CSF was lowered by 
implantation of a lumbar-intraperitoneal CSF shunt. 
Health of the optic tissues was monitored using optical 
coherence tomography. The authors reported that two 
of the four experimental animals showed characteristic 
signs of glaucomatous pathology after ICP was lowered 
by at least 5 mmHg (57). Although the monkey model of 
Yang and colleagues is extremely relevant and an elegant 
setup (57), the IVC model is comparatively inexpensive 
and would require less upkeep and operational budget. 
Nevertheless, both these animal models will help us 
better understand the role of ICP and TLPG in 
glaucomatous pathogenesis. 
 
SUMMARY AND CONCLUDING REMARKS 
Cupping of the optic nerve head and the lamina cribrosa 
is a characteristic pathological manifestation of 
glaucoma. Under homeostatic conditions, the lamina 
cribrosa is subjected to a posteriorly directed pressure of 
roughly 4 mmHg (17). This pressure difference arises out 
of the posteriorly directed IOP and the anteriorly 
directed ICP which creates a pressure gradient across the 
lamina cribrosa, known as the TLPG. IOP and ICP are 
anatomically and physiologically interlinked pressure 
components and changes in one may be reflected by 
changes in the other within a biological range. Under 
pathological conditions like glaucoma, a low ICP in the 
presence or absence of a high IOP will cause an 
increasingly unbalanced posteriorly directed force on the 
lamina cribrosa. The thickness of the lamina cribrosa and 
the resulting elastic resilience of the surrounding sclera 
also play a significant role in maintaining the homeostatic 
condition around the optic nerve head. 
Considering all retrospective, prospective and 
experimental evidences, ICP should be regarded as an 
important factor in the progression of glaucoma. Studies 
in animal models like the rat IVC model will enable the 
determination of the relationship between ICP, IOP and 
glaucoma. Standardizing non-invasive and surrogate 
techniques to identify ICP values will be of particular 
importance, since current methods are highly invasive 
and dangerous (59, 89, 90). Notwithstanding the 
technical difficulties, the current data should help 
educate the clinical and research communities about the 
importance of ICP in diagnosis and treatment of 
glaucoma. Hopefully, the knowledgeable physician will 
now look for signs of glaucoma in patients with subtle 
neurological symptoms of low ICP like postural 
headaches and sixth nerve weakness (3).  
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